Surgical Management of the Breast. Breast Conservation Therapy and Mastectomy.

Surgical Clinics of North America

Volumn 93, Issue 2, 2013, Pages 411-428

  McLaughlin, Sarah A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast conservation; Breast conservation surgery; Local recurrence; Margins; Mastectomy; Surgical trends

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB;

ADJUVANT THERAPY; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CATHETER; DISEASE FREE SURVIVAL; FEMALE; GENE MUTATION; HUMAN; MAMMOGRAPHY; MASTECTOMY; META ANALYSIS (TOPIC); METASTASIS; MICROSCOPY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PATIENT SATISFACTION; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REVIEW; SEGMENTAL MASTECTOMY; SUBCUTANEOUS MASTECTOMY; TREND STUDY; TUMOR VOLUME; UNITED STATES;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MASTECTOMY, RADICAL; MASTECTOMY, SEGMENTAL; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 84875328859     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2012.12.006     Document Type: Review

References (76)

1. Fisher B., Jeong J.H., Anderson S., et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002, 347(8):567-575.
2. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347(16):1233-1241.
3. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991, 265(3):391-395.
4. Available at:. http://www.nccn.org.
5. Dang C.M., Zaghiyan K., Karlan S.R., et al. Increased use of MRI for breast cancer surveillance and staging is not associated with increased rate of mastectomy. Am Surg 2009, 75(10):937-940.
6. Pettit K., Swatske M.E., Gao F., et al. The impact of breast MRI on surgical decision-making: are patients at risk for mastectomy?. J Surg Oncol 2009, 100(7):553-558.
7. McGuire K.P., Santillan A.A., Kaur P., et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 2009, 16(10):2682-2690.
8. Arrington A.K., Jarosek S.L., Virnig B.A., et al. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 2009, 16(10):2697-2704.
9. Katipamula R., Degnim A.C., Hoskin T., et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009, 27(25):4082-4088.
10. Adkisson C.D., Vallow L.A., Kowalchik K., et al. Patient age and preoperative breast MRI in women with breast cancer: biopsy and surgical implications. Ann Surg Oncol 2011, 18(6):1678-1683.
11. Adkisson C.D., Bagaria S.P., Parker A.S., et al. Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer?. Ann Surg Oncol 2012, 19(4):1129-1136.
12. Carpenter S.G., Stucky C.C., Dueck A.C., et al. Scientific presentation award: the impact of magnetic resonance imaging on surgical treatment of invasive breast cancer. Am J Surg 2009, 198(4):475-481.
13. Habermann E.B., Abbott A., Parsons H.M., et al. Are mastectomy rates really increasing in the United States?. J Clin Oncol 2010, 28(21):3437-3441.
14. Garcia-Etienne C.A., Tomatis M., Heil J., et al. Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database. Eur J Cancer 2012, 48(13):1947-1956.
15. Tuttle T.M., Habermann E.B., Grund E.H., et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 2007, 25(33):5203-5209.
16. King T.A., Sakr R., Patil S., et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 2011, 29(16):2158-2164.
17. Nichols H.B., Berrington de Gonzalez A., Lacey J.V., et al. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 2011, 29(12):1564-1569.
18. Abbott A., Rueth N., Pappas-Varco S., et al. Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol 2011, 18(11):3129-3136.
19. Guth U., Myrick M.E., Viehl C.T., et al. Increasing rates of contralateral prophylactic mastectomy - a trend made in USA?. Eur J Surg Oncol 2012, 38(4):296-301.
20. Veronesi U., Volterrani F., Luini A., et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 1990, 26(6):671-673.
21. Arentz C., Baxter K., Boneti C., et al. Ten-year experience with hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann Surg Oncol 2010, 17(Suppl 3):378-383.
22. Van Esser S., Hobbelink M., Van der Ploeg I.M., et al. Radio guided occult lesion localization (ROLL) for non-palpable invasive breast cancer. J Surg Oncol 2008, 98(7):526-529.
23. Hughes J.H., Mason M.C., Gray R.J., et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J 2008, 14(2):153-157.
24. McGhan L.J., McKeever S.C., Pockaj B.A., et al. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution. Ann Surg Oncol 2011, 18(11):3096-3101.
25. Mendez J.E., Lamorte W.W., de Las Morenas A., et al. Influence of breast cancer margin assessment method on the rates of positive margins and residual carcinoma. Am J Surg 2006, 192(4):538-540.
26. Wright M.J., Park J., Fey J.V., et al. Perpendicular inked versus tangential shaved margins in breast-conserving surgery: does the method matter?. J Am Coll Surg 2007, 204(4):541-549.
27. Houssami N., Macaskill P., Marinovich M.L., et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 2010, 46(18):3219-3232.
28. McCahill L.E., Single R.M., Aiello Bowles E.J., et al. Variability in reexcision following breast conservation surgery. JAMA 2012, 307(5):467-475.
29. Kearney T.J., Morrow M. Effect of reexcision on the success of breast-conserving surgery. Ann Surg Oncol 1995, 2(4):303-307.
30. Bleicher R.J., Ciocca R.M., Egleston B.L., et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 2009, 209(2):180-187. [quiz: 294-5].
31. Houssami N., Ciatto S., Macaskill P., et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008, 26(19):3248-3258.
32. Turnbull L., Brown S., Harvey I., et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 2010, 375(9714):563-571.
33. Pengel K.E., Loo C.E., Teertstra H.J., et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat 2009, 116(1):161-169.
34. Peters N.H., van Esser S., van den Bosch M.A., et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer 2011, 47(6):879-886.
35. Fischer U., Zachariae O., Baum F., et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004, 14(10):1725-1731.
36. Solin L.J., Orel S.G., Hwang W.T., et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008, 26(3):386-391.
37. Sardanelli F., Giuseppetti G.M., Panizza P., et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 2004, 183(4):1149-1157.
38. Wapnir I.L., Anderson S.J., Mamounas E.P., et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006, 24(13):2028-2037.
39. Fisher B., Brown A., Mamounas E., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997, 15(7):2483-2493.
40. Rastogi P., Anderson S.J., Bear H.D., et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 2008, 26(5):778-785.
41. Mieog J.S., van der Hage J.A., van de Velde C.J. Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev 2007, (2). CD005002.
42. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366(9503):2087-2106.
43. Darby S., McGale P., Correa C., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011, 378(9804):1707-1716.
44. Dershaw D.D., McCormick B., Osborne M.P. Detection of local recurrence after conservative therapy for breast carcinoma. Cancer 1992, 70(2):493-496.
45. Meyers M.O., Klauber-Demore N., Ollila D.W., et al. Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. Ann Surg Oncol 2011, 18(10):2851-2857.
46. Voduc K.D., Cheang M.C., Tyldesley S., et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010, 28(10):1684-1691.
47. Romond E.H., Perez E.A., Bryant J., et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005, 353(16):1673-1684.
48. Mamounas E.P., Tang G., Fisher B., et al. Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol 2010, 28(10):1677-1683.
49. Salvadori B., Marubini E., Miceli R., et al. Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery. Br J Surg 1999, 86(1):84-87.
50. Galper S., Blood E., Gelman R., et al. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2005, 61(2):348-357.
51. Anderson S.J., Wapnir I., Dignam J.J., et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 2009, 27(15):2466-2473.
52. Toth B.A., Lappert P. Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning. Plast Reconstr Surg 1991, 87(6):1048-1053.
53. Sotheran W.J., Rainsbury R.M. Skin-sparing mastectomy in the UK-a review of current practice. Ann R Coll Surg Engl 2004, 86(2):82-86.
54. Kinoshita S., Nojima K., Takeishi M., et al. Retrospective comparison of non-skin-sparing mastectomy and skin-sparing mastectomy with immediate breast reconstruction. Int J Surg Oncol 2011, 2011:876520.
55. Freeman B.S. Subcutaneous mastectomy for benign breast lesions with immediate or delayed prosthetic replacement. Plast Reconstr Surg Transplant Bull 1962, 30:676-682.
56. Jabor M.A., Shayani P., Collins D.R., et al. Nipple-areola reconstruction: satisfaction and clinical determinants. Plast Reconstr Surg 2002, 110(2):457-463.
57. Lagios M.D., Gates E.A., Westdahl P.R., et al. A guide to the frequency of nipple involvement in breast cancer. A study of 149 consecutive mastectomies using a serial subgross and correlated radiographic technique. Am J Surg 1979, 138(1):135-142.
58. Luttges J., Kalbfleisch H., Prinz P. Nipple involvement and multicentricity in breast cancer. A study on whole organ sections. J Cancer Res Clin Oncol 1987, 113(5):481-487.
59. Morimoto T., Komaki K., Inui K., et al. Involvement of nipple and areola in early breast cancer. Cancer 1985, 55(10):2459-2463.
60. Simmons R.M., Brennan M., Christos P., et al. Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved?. Ann Surg Oncol 2002, 9(2):165-168.
61. Vyas J.J., Chinoy R.F., Vaidya J.S. Prediction of nipple and areola involvement in breast cancer. Eur J Surg Oncol 1998, 24(1):15-16.
62. Rusby J.E., Brachtel E.F., Othus M., et al. Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy. Br J Surg 2008, 95(11):1356-1361.
63. Boneti C., Yuen J., Santiago C., et al. Oncologic safety of nipple skin-sparing or total skin-sparing mastectomies with immediate reconstruction. J Am Coll Surg 2011, 212(4):686-693. [discussion: 93-5].
64. Kim H.J., Park E.H., Lim W.S., et al. Nipple areola skin-sparing mastectomy with immediate transverse rectus abdominis musculocutaneous flap reconstruction is an oncologically safe procedure: a single center study. Ann Surg 2010, 251(3):493-498.
65. Lanitis S., Tekkis P.P., Sgourakis G., et al. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies. Ann Surg 2010, 251(4):632-639.
66. Dahlstrom K.K., Andersson A.P., Andersen M., et al. Wide local excision of recurrent breast cancer in the thoracic wall. Cancer 1993, 72(3):774-777.
67. Downey R.J., Rusch V., Hsu F.I., et al. Chest wall resection for locally recurrent breast cancer: is it worthwhile?. J Thorac Cardiovasc Surg 2000, 119(3):420-428.
68. Jacobson J.A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995, 332(14):907-911.
69. van Dongen J.A., Bartelink H., Fentiman I.S., et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 1992, (11):15-18.
70. Blichert-Toft M., Nielsen M., During M., et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 2008, 47(4):672-681.
71. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347(16):1227-1232.
72. Sarrazin D., Le M.G., Arriagada R., et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989, 14(3):177-184.
73. Powles T.J., Hickish T.F., Makris A., et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995, 13(3):547-552.
74. van der Hage J.A., van de Velde C.J., Julien J.P., et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001, 19(22):4224-4237.
75. Yi M., Kronowitz S.J., Meric-Bernstam F., et al. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer 2011, 117(5):916-924.
76. Gerber B., Krause A., Dieterich M., et al. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg 2009, 249(3):461-468.